BACKGROUND: Soft-tissue sarcomas (STSs) are a heterogeneous group of malignant tumors that can be difficult to treat. This is particularly true after incomplete or unplanned excisions and especially for patients with American Joint Committee on Cancer stage III tumors, who are at high risk for relapse. Numerous studies have shown that an inadequate sarcoma excision is associated with a worse prognosis. However, other reports have suggested an improved prognosis for patients with an initial unplanned excision and subsequent re-excision in comparison with patients who undergo planned primary surgery. The purpose of this study was to determine the impact of an unplanned excision on treatment and subsequent oncologic and functional outcomes for patients with stage III extremity STS. METHODS: From the prospectively collected database at a tertiary-referral sarcoma center, all patients with stage III STS of the extremities treated between 1989 and 2010 were identified. Patient records were reviewed to identify patient demographics, tumor details, treatments, complications, and functional and oncologic outcomes. RESULTS: Five hundred patients with stage III STSs of the extremities were identified, and 94 of these patients (18.8%) were referred after inadequate excisions had been performed elsewhere. All 94 patients with unplanned excisions underwent re-excision in an attempt to achieve clear margins, and 83% of these patients had residual tumor in the re-excision specimen. In the re-excision group, the rates of plastic reconstruction (eg, skin grafts and rotational or free flaps) and amputation were significantly higher in comparison with the rates for patients who underwent a primary planned resection (P = .023 and P = .03, respectively). The rates of local recurrence, metastasis-free survival, and overall survival were not significantly different between the 2 groups, nor were the functional outcomes. CONCLUSIONS: Unplanned excision of stage III STS leads to an unfavorable clinical course and necessitates more extensive surgery. As a result of aggressive re-excision and multidisciplinary treatment, a negative effect on oncologic outcomes cannot be confirmed. Cancer 2018;124:3868-3875.
INTRODUCTION
Soft-tissue sarcomas (STSs) are a heterogeneous group of primary malignant tumors arising from tissue of mesodermal origin and constitute approximately 1% of all malignancies. 1 Because extremity STSs are rare and benign soft-tissue tumors are comparatively common, it is inevitable that some sarcomas will be inappropriately excised by nonsarcoma surgeons under the assumption that they are benign. This is a ubiquitous problem at specialty centers treating patients with extremity STSs. [2] [3] [4] Referrals after an initial inadequate or unplanned excision of an STS, which is often referred to as a "whoops" procedure, represent 19% to 53% of new patients seen in sarcoma centers. 1, 3, 5 The mainstay of treatment for patients who have undergone an unplanned excision of an extremity STS is re-resection of the tumor bed with wide or at least negative margins. This practice is often straightforward in patients with small, superficial tumors, but the situation becomes more complex after an unplanned excision elsewhere if the tumor is large, high-grade, and deep to fascia (American Joint Committee on Cancer [AJCC] stage III) because of the proximity of neurovascular structures and the amount of functional muscle that becomes contaminated and, therefore, requires re-resection. Numerous studies have shown that positive resection margins after re-excision in this setting are associated with a worse prognosis, with these patients experiencing higher rates of local recurrence and potentially higher rates of metastases and decreased overall survival as well. [6] [7] [8] [9] [10] Local recurrence itself can be a devastating complication for patients because limb salvage cannot always be achieved. However, after the re-excision of an STS with wide or negative resection margins, some studies
Cancer October 1, 2018 have found local recurrence, metastasis, and survival rates similar to those after an initial primary surgery. [11] [12] [13] Several publications have even stated that patients who undergo re-excision surgery have superior oncologic outcomes in comparison with those who undergo primary surgery. [14] [15] [16] [17] These previous studies included all patients with unplanned excisions of extremity STS, including those with small and superficial tumors, whose outcomes are expected to be superior, and those with large and deep tumors, which would be associated with worse prognoses. Thus, the impact of unplanned excisions of STS on disease recurrence remains controversial. 18 The purpose of this study was to compare the outcomes of patients with AJCC stage III extremity STS who had undergone prior unplanned excisions with the outcomes of patients undergoing primary surgery at a sarcoma referral center. This group of patients was selected for investigation because they are at highest risk for developing recurrent disease in general, and after poor initial treatment, they may have even worse outcomes; this makes them an ideal cohort for studying the effects of planned and unplanned excisions. The primary outcomes of interest were overall survival, metastasis-free survival, and local recurrence-free survival. Secondary measures included functional outcomes, rates of surgical complications, rates of extremity amputation, and types of soft-tissue reconstruction required for wound closure.
MATERIALS AND METHODS
After obtaining research ethics board approval, we reviewed our prospectively collected STS database at Mount Sinai Hospital and Princess Margaret Cancer Center, Toronto, Ontario, Canada to identify patients with AJCC stage III extremity STS (large [≥5 cm], deep, high-grade, and nonmetastatic) 19 treated between 1986 and 2010 who had undergone definitive surgical resection at Mount Sinai Hospital, Toronto, Ontario, Canada and had a minimum of 24 months of follow-up (for living patients). Patients with metastatic disease at presentation were excluded, as were those who had undergone a prior primary resection of a stage III sarcoma at our center and presented with a local recurrence. In comparison, all patients who had undergone an incomplete excision of a stage III tumor elsewhere were included because even if they had obvious recurrent disease at the surgical site upon their initial assessment at our clinic, it was considered to represent residual disease. Of the 2135 patients in our STS database, 500 met the inclusion criteria and were included in this study. Patients were classified into 2 groups: the plannedresection group (group 1) was composed of patients who were referred before any surgical treatment and subsequently underwent primary excision (n = 406 [81.2%]), and the unplanned-resection group (group 2) included patients who were referred after undergoing an unplanned excision of an STS elsewhere and subsequently underwent a definitive re-excision procedure (n = 94 [18.8%] ).
All patients underwent surgical resection with the aim of obtaining a negative surgical margin around the tumor and/or the previous surgical site whenever possible. In the unplanned-excision group (group 2), any residual/recurrent tumor, hematoma, or edema remaining from the unplanned excision procedure was evaluated before additional surgery with magnetic resonance imaging. A multidisciplinary discussion of every patient was undertaken to determine the necessity for adjuvant radiation and/or chemotherapy. In general, chemotherapy was used rarely and only for patients with known sensitive tumors such as extraskeletal Ewing sarcoma and for some patients with synovial sarcoma or extraskeletal osteosarcoma after a multidisciplinary tumor board discussion. For the portion of the study period between 1994 and 1997, a randomized controlled trial of preoperative radiotherapy versus postoperative radiotherapy was ongoing; however, on the basis of the results of that study, our preference is to use preoperative radiation for patients with extremity STS whenever possible. [20] [21] [22] After surgery, patients were checked every 3 months with physical examinations (to be evaluated for local or regional recurrence) and chest radiographs (to be evaluated for metastases) for 2 years, every 6 months thereafter for the next 3 years, and then annually for another 5 years. Function was assessed with the physician-derived Musculoskeletal Tumor Society 1987 and 1993 rating scales 23 and with the patientcompleted Toronto Extremity Salvage Score. 24 Statistical analyses of demographic variables (sex and age), pathological variables (tumor histology, anatomic site, tumor size, resection margins, and presence of residual tumor after re-excision), and therapeutic variables (planned excision vs unplanned excision, type of surgery, complications, radiotherapy, and chemotherapy) in both groups were performed. Tumor size was determined on the basis of the initial preoperative imaging studies in both groups. However, for group 2 patients, preoperative images were not always available. In these cases, the size was calculated from the pathology report from the referring center by the addition of the maximum diameters of all resected pieces of the tumor. The margin status was defined by the presence
or absence of tumor cells at the inked margin of the resection or re-resection specimen. The primary endpoints of the study were overall survival, metastasis-free survival, and local recurrence-free survival. Secondary endpoints included the functional outcomes, the incidence of surgical wound complications, the extremity amputation rate, and the necessity for soft-tissue coverage with flaps. Descriptive summary statistics included means, frequencies, and proportions. Age and time intervals between operations were regarded as continuous variables, and all other covariates were modeled as categorical variables. Differences between means and proportions were tested with the t test for continuous variables and with the chi-square test for categorical variables. Actuarial survival was estimated with the Kaplan-Meier method. Significant differences between survival curves were identified by the log-rank test. We performed a multivariate analysis for factors affecting overall, metastasis-free, and local recurrence-free survival rates with stepwise Cox proportional hazards regression analysis. Statistical analysis was performed with SPSS 20.0 (SPSS, Inc, Chicago, Illinois). A P value ≤ .05 was considered statistically significant.
RESULTS
There were no differences in the age at surgery, sex, histologic subtype, or anatomic location between patients who underwent planned excisions (group 1) and patients who underwent unplanned excisions (group 2; P for all comparisons > .05; Table 1 ). The maximum tumor size was smaller in the unplanned-excision group (mean, 10.3 cm; range, 5-33.5 cm) than the plannedexcision group (mean, 12.5 cm; range, 5.2-39.5 cm; P = .002). Adjuvant radiotherapy was administered equally and frequently (85%) in both patient groups but was also used more commonly preoperatively than postoperatively in both patient groups (group 1, 67.8% vs 26.7%; group 2, 73.8% vs 21.2%; Table 2 ). Adjuvant chemotherapy was used equally but rarely. The average patient follow-up was 54 months (range, 1-226 months) in group 1 and 61.6 months (range, 1-228 months) in group 2. There was no significant difference between the 2 groups with respect to the final resection margins. There were 66 positive margins among 406 patients (16.3%) in group 1 and 12 among 94 patients (12.8%) in group 2 (P = .4). There was also no significant difference in the rate of local recurrence (8.2% for group 1 vs 10.6% for group 2; P = .53). However, the definitive surgical margin after resection was a strong predictor of outcomes in both groups because a positive margin led to a significantly higher local recurrence rate (P = .027). In addition, of the 94 patients in group 2, 69 (73.4%) had gross residual disease, and 9 (9.6%) had microscopic residual tumor identifiable in the re-excision specimen. There were no local recurrences among the 16 patients with no residual disease in the re-excision specimen, whereas 10 of the 78 patients with residual identifiable disease (12.8%) had local recurrences (P = .2).
Actuarial overall survival rates and metastasis-free and local recurrence-free survival rates were not significantly different between the treatment groups (Fig. 1) . The 5-year overall survival rate was 54% for patients who underwent an initial unplanned resection (group 2) and Cancer October 1, 2018 50.1% after a planned resection (group 1; P = .3). The 5-year metastasis-free survival rate was 53.1% for patients after an unplanned resection (group 2) and 44.3% after a planned resection (group 1; P = .42). The 5-year local recurrence-free survival rate was 88.3% for patients after an unplanned excision (group 2) and 90.1% after a planned resection (group 1; P = .29). For patients who underwent an initial unplanned resection elsewhere (group 2), the apparent increased risk of local recurrence based on the presence of identifiable residual tumor in the re-excision specimen was not significant (P = .1; Fig.1D ).
For patients who underwent an initial unplanned resection elsewhere (group 2), amputation (P = .03) was required significantly more often in comparison with patients who underwent planned sarcoma resections (group 1; Table 3 ). After an unplanned excision, patients who underwent re-excision and limb-sparing surgery required more plastic surgery interventions, including split thickness skin grafts and rotational and free flap reconstructions, in comparison with patients who underwent initial planned resections (P = .023). After initial unplanned resections, 17 of 94 patients (18.1%) required an amputation, whereas 41 of 406 patients (10.1%) did after planned surgery. After an initial unplanned excision followed by limb-sparing surgery, 36 of 77 patients (46.8%) required plastic surgery reconstruction, whereas 121 of 365 patients (33.2%) did after planned surgery. The incidence of postoperative complications that necessitated additional revision surgery (eg, wound dehiscence or necrosis and deep infections) was not significantly different between the 2 groups (P = 0.2). There were also no differences in functional outcomes between patients who underwent planned surgeries and patients who underwent unplanned surgeries (Table 4 ). In the multivariate analysis, we were unable to identify any parameter that increased the risk of overall, metastasis-free, and local recurrence-free survival rates.
DISCUSSION
We focused our study on a well-defined group of patients who all had high-risk, AJCC stage III extremity STS so that we could compare the outcomes of 2 groups of patients: those who underwent a single primary planned resection at a specialist sarcoma institution and those who underwent re-resection after an initial unplanned incision performed elsewhere. We selected this group of patients because they all had tumors with similar high-risk prognostic factors (eg, large [≥5 cm], deep, and high-grade), and this is the most difficult scenario to salvage after an unplanned excision. There is no doubt that the inadvertent excision of a tumor that turns out to be an STS frequently leaves behind residual tumor cells, and this makes further treatment essential. It should be noted that the incidence of residual identifiable disease in patients who underwent initial unplanned resections (group 2) in our series was very high (83%), exceeding the incidence of many other reports. 3, 9, 12 This justifies the practice of recommending routine re-excision of the tumor bed after an initial unplanned excision for patients in group 2.
Surprisingly, we could not show that previous unplanned excisions of stage III extremity STS had a significant negative effect on overall, metastasis-free, or local recurrence-free survival. However, we once again identified positive margins as the main predictor of local recurrence. However, the context of a positive margin 10, [25] [26] [27] must also be taken into consideration because it provides important case-specific predictive information about the risk of both local recurrence and metastasis. For example, a planned close but ultimately positive margin to salvage critical structures, including major nerves, vessels, and bone, would be expected to occur occasionally during resections of large, deep, high-grade sarcomas in group 1, and it is known to be associated with a low risk of local recurrence but a high risk of metastasis, whereas an inadvertent positive soft-tissue margin in a similar setting would be associated with higher rates of both local and systemic relapse. 25, 27 It seems that the biologic aggressiveness inherent to an STS that invades critical structures portends a worse overall prognosis, regardless of the quality of the surgical margin. We also found that residual identifiable sarcoma within the re-excision specimen increased the risk of local recurrence (Fig. 1D) . Among the 94 patients in group 2, there were 10 local recurrences in 78 patients (12.8%) with residual tumor identified in the re-excision specimen, whereas there were no recurrences in 16 patients with no residual identifiable disease. Although this difference was not significant (P = .1) in the current study, in a previous investigation, 6 we identified that residual disease after a prior unplanned resection led to a similar rate of local recurrence (7 of 42 [16.7%]) but was in fact a strong independent predictor for local tumor relapse; this finding is supported by the results of Chandrasekar et al. 3 The results of this study indicate that an unplanned resection (group 2) has a negative impact on the type and extent of definitive surgical management. More frequent advanced soft-tissue reconstructive procedures in the form of local and free flaps were needed after initial unplanned resections. Despite more extensive surgery and more frequent use of flaps for patients in group 2, surprisingly, we did not find a difference in functional outcomes between the 2 study groups. However, we recognize that our functional assessment tools are specific to the primary tumor site and do not evaluate donor site morbidity. For example, although donor site complaints are infrequent after anterolateral thigh free flaps, after free latissimus flaps, there can be significant shoulder weakness manifesting as difficulties with sports and art activities. 28, 29 More concerning is the fact that amputations were also required more frequently after prior unplanned excisions, and this confirms that more extensive surgery is required to salvage the soft-tissue contamination caused by the initial inadequate procedure. The anatomic proximity of many stage III STSs to neurovascular structures, bones, and joints and their potential subsequent contamination after initial unplanned excisions clearly result in a significantly higher need for amputations for definitive management. Most cases of amputation performed after unplanned excisions (group 2) could have been avoided if correct oncologic-surgical principles had been respected initially on the basis of the evaluation of each patient at weekly multidisciplinary case conference review meetings. 12, 14 The incidence of local recurrence in this study for patients with stage III extremity STS was 8.2% in the primary excision group and 10.6% in the unplannedexcision group (P = .53); these rates are similar to those reported by Cahlon et al. 30 In comparison, a study of 10,000 patients with STS from the Memorial Sloan Kettering Cancer Center reported an overall local recurrence rate for all stages of extremity STS of 20% at 10 years. 19 Chandrasekar et al 3 from Birmingham, United Kingdom, studied 316 patients with STS who underwent re-excision after an initial unplanned resection, and they reported a local recurrence-free survival rate of 21% at 5 years. We relate the lower local recurrence rate in our series, particularly for patients in group 2, to our radical surgical approach to salvaging patients who present after incomplete excisions performed elsewhere for stage III STS; this is exemplified by the higher rates of flaps and amputations used for patients in group 2 in this study. We also believe that our multidisciplinary approach to sarcoma patient care, which frequently includes the use of preoperative or postoperative radiation, also plays an important role in achieving low rates of local recurrence. 26, 31 Each new sarcoma patient at our clinic is reviewed by a multidisciplinary team composed of musculoskeletal pathologists and radiologists and surgical, medical, and radiation oncologists. This allows for specialized pathology and radiology input to help to determine the extent of contamination caused by the initial unplanned excision, including the location of residual tumor, hemorrhage, and perilesional edema, 32 which all need to be taken into account for both radiation and surgical planning. This hypothesis is supported by studies by Lewis et al 15 and Zagars et al, 2 which also demonstrated very high rates of local control in patients after adequate re-resection at a sarcoma center. Although the impact of adjuvant radiotherapy on overall and metastasis-free survival remains unclear from this and other studies, radiotherapy is routinely used in most centers for patients with stage III sarcomas to improve local control. [1] [2] [3] 14, 33 In our study, other than patients who required amputation, almost all limb-salvage patients with AJCC stage III STS were treated with radiotherapy, and preoperative radiation was used preferentially in both patient groups, largely because of its known association with improved functional outcomes. 22 In conclusion, we observed no difference in oncologic outcomes between patients with AJCC stage III extremity STS who underwent initial unplanned
Cancer October 1, 2018 excisions and those initially resected at a specialty center. A negative-margin re-excision in patients after an initial unplanned excision performed elsewhere definitely improved local control. These results demonstrate that the expertise and multidisciplinary treatment of patients at a specialized center can largely compensate for inadequate initial treatment. However, these patients required more extensive surgery, more flaps and skin grafts, and, unfortunately, more amputations to achieve high rates of local control. Therefore, the unplanned excision of a high-risk STS should still be avoided if at all possible because it necessitates more extensive surgery, including more frequent amputations.
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